Clinical Trial Record

Return to Clinical Trials

Effects of Chewing Gum Against Postoperative Ileus


2021-02-14


2023-03


2023-05


10

Study Overview

Effects of Chewing Gum Against Postoperative Ileus

The purpose of this study is to determine whether the use of chewing gum effects postoperative ileus after pancreaticoduodenectomy

Postoperative ileus is common after surgery. One non-pharmacological intervention that has shown promising results in reducing the duration of postoperative ileus is chewing gum after surgery. However, this has not been investigated in upper gastrointestinal surgery such as pancreatic surgery. Hence the aim of this study was to investigate the effects of chewing gum treatment on patients undergoing pancreaticoduodenectomy due to pancreatic or periampullary cancer. This study was conducted as a phase-III trial. Patients diagnosed with pancreatic tumours scheduled for pancreaticoduodenectomy were included. The treatment group received chewing gum postoperatively and standard care. Controls received glucose solution and standard care.

  • Pancreas Neoplasm
  • OTHER: gum
  • chewing gum postoperative

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2021-02-21  

N/A  

2021-02-21  

2021-02-21  

N/A  

2021-02-24  

2021-02-24  

N/A  

2020-09  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Other


Allocation:
Na


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
OTHER: normal

people will not use chewing gums after whipple operation

OTHER: gum

  • Other: Chewing gum ChiczaTM organic chewing gum 6 pieces a day Other: Glucose 12ml glucose solution (13,6g) per day
Primary Outcome MeasuresMeasure DescriptionTime Frame
First flatus after surgeryFrom day of surgery until first postoperative flatus(with in the first 21 days)
Length of hospital stayTime Frame: From day of surgery until discharge from surgical ward(with in the first 21 days) ]
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: andrew mokbel

Phone Number: 01090981160

Email: andrew.sawers55@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:

Accepts Healthy Volunteers:
1

    Inclusion Criteria:
    1. Pancreatic or periampullary cancer and scheduled to undergo pancreaticoduodenectomy.
    Exclusion Criteria:

  • 2. Ongoing treatment for mental disease 3. Diagnosed neurological injuries or diseases affecting the ability to swallow or gastric function 4. Ongoing abuse of alcohol or other drugs 5. Previously known allergies to the content of chewing gum 6. Additional surgery after primary surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available